(NQ: )

N/A UNCHANGED

Last Price Updated: Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	-
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	N/A
Dividend Yield	N/A

Chart for (: )

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

Cytori Therapeutics Reminds Investors of Today’s Deadline to be a Shareholder of Record

June 22, 2018

Cytori Therapeutics, Inc. (NASDAQ:CYTX) (“Cytori” or the “Company”) today issued a reminder to shareholders that the Record Date of its proposed rights offering is June 26, 2018. To be a shareholder of...

The Stem Cell Market is Projected to Grow Due to Technological Advancements

May 31, 2018

FinancialBuzz.com News Commentary

Performance

More News

Cytori Reports Q1 2018 Business and Financial Results

May 10, 2018

Cytori to Webcast First Quarter Financial Results on May 10

May 07, 2018

Cytori Provides Update on US Manufacturing and EU Approval Plans for ATI-0918, Liposomal Doxorubicin

April 30, 2018

Enrollment Completed in ADRESU Clinical Trial of Cytori Cell Therapy™ for Stress Urinary Incontinence

March 28, 2018

Cytori Reports Fourth Quarter and Full Year 2017 Business and Financial Results

March 08, 2018

Cytori to Webcast Fourth Quarter Financial Results on March 8th

February 22, 2018

Cytori Scleroderma Trial Data Presented at Systemic Sclerosis World Congress

February 15, 2018

Cytori Therapeutics Announces Inducement Grants for New Employees

February 09, 2018

Enrollment Completed in Randomized Clinical Trial of Habeo™ Cell Therapy for Scleroderma and Impaired Hand Function

January 22, 2018

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.